Prostate Cancer Treatment Act which

Prostate cancer treatment, There are mainly surgical treatment, hormone therapy, chemotherapy, radiotherapy, such as immune therapy. Specific selection of the methods should be based on patient's age, general condition, cancer and a partial transfer of the case may be.
(1) Surgical treatment: 1) prostate cancer radical operation, and its scope includes the prostate gland and prostate capsule; 2) pelvic lymphadenectomy; 3) Transurethral resection of the prostate, mainly for the lifting of bladder neck obstruction.
(2) endocrine treatment with the drug adrenal: Endocrine current law is already prostate cancer, especially advanced prostate cancer treatment. 1) Estrogen drugs; 2) anti - androgen drugs, including steroid and non-steroid two categories; 3) promote gonadal releasing hormone analogues (GnRH-A); 4) Anti-adrenal drugs.
(3) lower androgen testosterone Endocrine Surgical treatment: 1) testis resection, often combined with other treatments, can obtain better therapeutic effect; 2) adrenal and pituitary resection resection of the clinical effect than worse, the larger of injury, has not adopted.
(4) Chemical treatment: prostate cancer chemotherapy in 1973 for clinical, and many scholars believe that the combination of the two drugs results in the use of a single drug properly.
(5) radiation therapy: Radiation treatment of prostate cancer has more than 60 years of history, mainly in the following ways: 1) in vitro radiotherapy; 2) the organization radiotherapy, and in this way often or prostate cancer radical operation combined with pelvic lymphadenectomy for 3) systemic radiotherapy: to a certain extent, can alleviate the pain of bone metastasis and reducing disease development.
(6) Freeze therapy: This method applies to the relatively large size of the prostate tumors, in patients with systemic situation worse, the patients may promote immunity, bone, lung, and other metastatic lesions occurred degradation. Due to the need for special equipment is not yet widely used.
(7) immunotherapy: When patients with prostate cancer treated with other methods reduced to a negligible amount, the application of in vivo immunotherapy removal of a small amount of residual cancer organizations may achieve better results.